RxDoctor Payments Data

Garrett Hull, DO

Family Medicine · Jefferson City, MONPI 1528685906

Payments from drug & device makers

$347in general payments, 2019–2025

Across 20 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$118
  • Lilly USA, LLC$45
  • Boehringer Ingelheim$35
  • Pfizer$31
  • Novo Nordisk$30
  • Amgen$30
  • plus $59 from 3 others

What the payments were for

  • Food & beverage$33496%
  • Education$144%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$347 in reported general payments places this provider in the 45th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$15,570
Medicare patients
56
Services billed
244

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide23$26,472
OzempicSemaglutide14$16,224
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$10,674
JanuviaSitagliptin Phosphate11$5,718
Rosuvastatin Calcium22$852
Gabapentin58$727
Omeprazole58$691
Atorvastatin Calcium85$487
Glipizide-MetforminGlipizide/Metformin Hcl11$482
Levothyroxine Sodium66$423
Hydrocortisone13$415
Losartan Potassium40$408
Ipratropium Bromide11$295
Finasteride22$281
Lisinopril68$253

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$45$26,47223 claims
Novo NordiskOzempic$30$16,22414 claims
GSKTrelegy Ellipta$13$10,67416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Jefferson City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →